₹1,129.10
+₹1.90 (+0.17%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹12,767 Cr
P/E
69.52
ROE
19.57%
ROCE
22.16%
About Sudeep Pharma Ltd
Sudeep Pharma engaged in business of manufacturing and selling pharmaceutical and neutracutical products and intermediaries, used by pharmaceutical and neutracutical industries globally.
Founded
1989
CEO
Sujit J Bhayani
Employees
740
HQ
Vadodara, India
About Sudeep Pharma Ltd
Sudeep Pharma engaged in business of manufacturing and selling pharmaceutical and neutracutical products and intermediaries, used by pharmaceutical and neutracutical industries globally.
Founded:1989
CEO:Sujit J Bhayani
Employees:740
HQ:Vadodara, India
Finished Products
1Sales
₹689.69Cr2Export Incentive income
₹5.54CrRaw Materials
1Cost of Material Consumed
₹287.58CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,180
52W Low
₹524
Volume92.75K
Avg VolumeN/A
BetaN/A
Dividend Yield0.18%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
69.52x
Valuation
P/B Ratio
14.45x
Valuation
EPS
₹16.26
Valuation
Dividend Yield
0.18%
Valuation
ROE
19.57%
Profitability
ROCE
22.16%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical, food and nutrition
+6.4%65.8%
₹330.5 Cr
Speciality ingredients
+15.4%34.2%
₹171.5 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
40.7%
International
59.3%
India40.7%
Others40.3%
USA19.0%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.17x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
11.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.